December 26, 2014 7:32 AM ET

Biotechnology

Company Overview of Ikaria, Inc.

Company Overview

Ikaria, Inc. engages in developing and commercializing biotherapeutic solutions for the critical care market. The company’s lead product is INOMAX (nitric oxide) for inhalation, which is a drug for the treatment of hypoxic respiratory failure associated with pulmonary hypertension in term and near-term infants. It offers INOMAX therapy package, which is an all-inclusive offering of drug product, drug delivery system, on-site training, and technical assistance and support. The company is also involved in investigating additional indications for INOMAX in bronchopulmonary dysplasia, and for inhaled nitric oxide with the INOpulse DS drug-delivery system as a drug-device combination product in p...

Perryville III Corporate Park

53 Frontage Road

Third Floor

P.O. Box 9001

Hampton, NJ 08827-9001

United States

Founded in 2006

471 Employees

Phone:

908-238-6600

Fax:

908-238-6633

Key Executives for Ikaria, Inc.

Chairman and Chief Executive Officer
Age: 54
Chief Financial Officer and Senior Vice President
Age: 47
Senior Vice President of Commercial Operations
Age: 48
Executive Vice President of Research and Development
Senior Vice President of Global Manufacturing and Operations
Compensation as of Fiscal Year 2014.

Ikaria, Inc. Key Developments

Ikaria Partners with Lee's Pharmaceutical Holdings

Ikaria, Inc. and Lee's Pharmaceutical Holdings Limited have signed a partnership agreement for the registration and commercialization of Ikaria's INOMAX(R) total care package throughout the People's Republic of China, Hong Kong, Macau and Taiwan.

Ikaria Presents at Fifth Annual ChinaBio(R) Partnering Forum 2013, May-29-2013

Ikaria Presents at Fifth Annual ChinaBio(R) Partnering Forum 2013, May-29-2013 . Venue: Shangri-La Hotel, 29 Zizhuyuan Road, Beijing 100089, China.

Ikaria, Inc. Presents at 2013 BIO International Convention, Apr-23-2013 02:00 PM

Ikaria, Inc. Presents at 2013 BIO International Convention, Apr-23-2013 02:00 PM. Venue: McCormick Place - Chicago Bulls Room, 2301 S. Lake Shore Drive, Chicago, IL 60616, United States. Speakers: Daniel Tassé, Chairman and Chief Executive Officer.

Similar Private Companies By Industry

Company Name Region
Ambit Biosciences Corporation United States
Neurolixis, Inc. United States
Perlstein Lab PBC United States
Precision BioSciences, Inc. United States
Phloronol, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ikaria, Inc., please visit www.ikaria.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.